Total Payments
$9,073
2024 Payments
$909.22
Companies
34
Transactions
630
Medicare Patients
1,167
Medicare Billing
$197,395
Payment Breakdown by Category
Food & Beverage$8,766 (96.6%)
Gifts$220.00 (2.4%)
Education$86.82 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,766 | 626 | 96.6% |
| Gift | $220.00 | 2 | 2.4% |
| Education | $86.82 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,437 | 231 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $899.15 | 59 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $832.26 | 62 | $0 (2024) |
| Janssen Biotech, Inc. | $768.06 | 65 | $0 (2023) |
| Gilead Sciences, Inc. | $724.29 | 48 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $627.66 | 8 | $0 (2023) |
| IRONWOOD PHARMACEUTICALS, INC | $346.99 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $251.58 | 16 | $0 (2023) |
| PFIZER INC. | $237.85 | 17 | $0 (2022) |
| Tosoh Bioscience, Inc. | $220.00 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $909.22 | 70 | ABBVIE INC. ($436.27) |
| 2023 | $2,423 | 128 | NESTLE HEALTHCARE NUTRITION INC. ($565.43) |
| 2022 | $1,378 | 111 | ABBVIE INC. ($416.44) |
| 2021 | $1,109 | 89 | AbbVie Inc. ($329.51) |
| 2020 | $412.48 | 27 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($93.28) |
| 2019 | $1,234 | 82 | AbbVie, Inc. ($161.44) |
| 2018 | $829.66 | 58 | AbbVie, Inc. ($237.07) |
| 2017 | $776.17 | 65 | AbbVie, Inc. ($300.72) |
All Payment Transactions
630 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $2.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $2.11 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $1.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: VIROLOGY | ||||||
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.04 | General |
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: LIVER DISEASE | ||||||
| 11/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: LIVER DISEASE | ||||||
| 09/03/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Immunology | ||||||
| 08/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.60 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.22 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.37 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $47.41 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 295 | 5,736 | $379,571 | $118,765 |
| 2022 | 4 | 229 | 259 | $45,565 | $21,194 |
| 2021 | 5 | 332 | 371 | $64,145 | $32,136 |
| 2020 | 7 | 311 | 353 | $58,715 | $25,300 |
Total Patients
1,167
Total Services
6,719
Medicare Billing
$197,395
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 11 | 5,400 | $265,500 | $90,535 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 130 | $44,642 | $11,865 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $35,248 | $7,902 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 87 | $20,171 | $5,470 | 27.1% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2023 | 30 | 35 | $10,290 | $2,148 | 20.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 11 | 18 | $3,720 | $844.74 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 96 | 110 | $19,555 | $9,561 | 48.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 55 | 55 | $15,010 | $6,438 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 81 | $9,925 | $4,760 | 48.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 13 | $1,075 | $434.18 | 40.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 112 | 125 | $21,250 | $11,086 | 52.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 80 | 80 | $21,200 | $9,773 | 46.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 102 | 127 | $15,240 | $8,212 | 53.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 23 | $5,175 | $2,630 | 50.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 15 | 16 | $1,280 | $435.00 | 34.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 58 | 58 | $15,370 | $7,300 | 47.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 79 | 93 | $15,810 | $6,869 | 43.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 110 | 135 | $16,200 | $6,768 | 41.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 18 | 18 | $4,050 | $1,701 | 42.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 14 | 14 | $2,450 | $980.83 | 40.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 11 | $2,915 | $924.14 | 31.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 21 | 24 | $1,920 | $756.93 | 39.4% |
About Dr. Mark Jonas, M.D
Dr. Mark Jonas, M.D is a Gastroenterology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1144219957.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Jonas, M.D has received a total of $9,073 in payments from pharmaceutical and medical device companies, with $909.22 received in 2024. These payments were reported across 630 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($8,766).
As a Medicare-enrolled provider, Jonas has provided services to 1,167 Medicare beneficiaries, totaling 6,719 services with total Medicare billing of $197,395. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Cincinnati, OH
- Active Since 10/14/2005
- Last Updated 06/25/2010
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1144219957
Products in Payments
- STELARA (Biological) $719.09
- ZENPEP (Drug) $627.66
- XIFAXAN (Drug) $579.69
- ENTYVIO (Biological) $411.87
- MAVYRET (Drug) $387.13
- RINVOQ (Biological) $326.52
- Entyvio (Biological) $319.78
- Linzess (Drug) $315.05
- Humira (Biological) $312.65
- LINZESS (Drug) $276.17
- HUMIRA (Biological) $271.97
- VIBERZI (Drug) $247.13
- XELJANZ (Drug) $220.81
- DIFICID (Drug) $210.57
- TRULANCE (Drug) $199.43
- Cimzia (Drug) $196.43
- Mavyret (Drug) $187.33
- Creon (Drug) $168.35
- SKYRIZI (Biological) $163.35
- REMICADE (Biological) $151.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Cincinnati
Anita Afzali, Md, MD
Gastroenterology — Payments: $1.0M
Gastroenterology $1.0M
Dr. Allan Peck, M.d, M.D
Gastroenterology — Payments: $481,678
Gastroenterology $481,678
Kara De Felice, M.d, M.D
Gastroenterology — Payments: $472,231
Gastroenterology $472,231
Dr. Ravi Ravinuthala, M.d, M.D
Gastroenterology — Payments: $401,840
Gastroenterology $401,840
Luis Lara, Md, MD
Gastroenterology — Payments: $174,958
Gastroenterology $174,958
Dr. Lisa Lestina, M.d, M.D
Gastroenterology — Payments: $163,406
Gastroenterology $163,406